Abstract:A novel biomimetic‐platform for covalent and site‐directed immobilization of oriented αIIbβ3 integrin heterodimers onto hydroxyl bearing surfaces, as with cell surface integrins, immobilized αIIbβ3 can be modulated to the active ligand‐binding conformation by divalent cations. This platform resists non‐specific interactions, is easily adapted to other structure dependent proteins and receptors, and has implications on the future of diagnosis and therapy. Many biotechnologies require direct contact between biomolecules and (semi)solid substrates. However, little information is available regarding site‐directed covalent surface immobilization of heterodimeric proteins. Integrins are heterodimeric, conformationally dependent membrane adhesion‐receptors, which are important in the (patho)biology of almost all human diseases. In this study, a biomimetic‐platform is developed for covalent and site‐directed immobilization of oriented integrin heterodimers onto most hydroxyl bearing surfaces, herein demonstrated on both glass‐slides and silica‐particles. This platform consists of a self‐assembled monolayer, upon which C‐terminal modified αIIbβ3 integrin extracellular domains are oriented and covalently anchored. As with cell surface integrins, the conformation of immobilized αIIbβ3 is switchable and can be modulated to the active ligand‐binding conformation by divalent cations. Furthermore, the αIIbβ3‐coupled silica particles display platelet‐mimetic hemostat function and co‐aggregate with platelets from both wild‐type and fibrinogen/von Willebrand factor double deficient mice, facilitating αIIbβ3‐non‐classical ligand discoveries. This work provides a biomaterial platform for functional multimeric protein‐substrate coupling, which should have broad impact on multiple fields of biology, biotechnology, and clinical diagnosis/therapy.

Binding of Small Molecules to an Adaptive Protein-Protein Interface.

Multi-Scaled Explorations of Binding-Induced Folding of Intrinsically Disordered Protein Inhibitor IA3 to Its Target Enzyme

Design of High Affinity Binders to Convex Protein Target Sites

Exploring the Binding Mechanism Between Human Profilin (PFN1) and Polyproline-10 Through Binding Mode Screening

Protein flexibility and ligand rigidity: a thermodynamic and kinetic study of ITAM-based ligand binding to Syk tandem SH2

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Robust de novo design of protein binding proteins from target structural information alone

Rapid in silico Design of Potential Cyclic Peptide Binders Targeting Protein-Protein Interfaces

Interleukin-2 druggability is modulated by global conformational transitions controlled by a helical capping switch

Peptide binder design with inverse folding and protein structure prediction

Maßgeschneiderte Liganden für Protein-Protein-Interaktionen

Diffusing protein binders to intrinsically disordered proteins

Heterodimeric Protein Surface‐Coupling Platform: Immobilization of Conformation Switchable and Functional αIIbβ3 Integrin

Combinatorial libraries of bipodal binders of the insulin receptor

Conformational And Binding Mode Assessment Of The Human Il‐3 Recognition By Its Alpha Receptor

A single-chain antibody/epitope system for functional analysis of protein-protein interactions

Predicting binding events in very flexible, allosteric, multi-domain proteins

De novo design of drug-binding proteins with predictable binding energy and specificity

A quantitative intracellular peptide binding assay reveals recognition determinants and context dependence of short linear motifs

Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains

Improved protein binder design using ꞵ-pairing targeted RFdiffusion